SCHEMBL11295491

SCHEMBL11295491

CC(=O)NCC(OC(C)=O)C1=CC2(CCCC2)c2ccccc21

nearest known ligand 0.36

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 8/20 0.36
MTNR1B P49286 8/20 0.36
APOBEC3A P31941 2/20 0.34
APOBEC3G Q9HC16 2/20 0.34
PABPC1 P11940 1/20 0.34
PDK2 Q15119 3/20 0.32
OPRM1 P35372 1/20 0.32
OPRL1 P41146 1/20 0.32
HDAC4 P56524 2/20 0.32
TSHR P16473 1/20 0.31
CASP1 P29466 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL11295494 0.82 MTNR1A (0.36) MTNR1AMTNR1BPDK2OPRM1OPRL1
SCHEMBL11503333 0.76 MTNR1A (0.33) MTNR1AMTNR1BHDAC4
SCHEMBL11291104 0.73 SMN1; SMN2 (0.42) MTNR1AMTNR1BHDAC4
SCHEMBL11288858 0.71 SLC6A4 (0.34) TSHR
SCHEMBL31452460 0.71 SLC6A4 (0.34) TSHR
SCHEMBL11544999 0.71 AKR1C1 (0.37) APOBEC3AAPOBEC3GPDK2HDAC4TSHR
SCHEMBL11294472 0.70 HDAC4 (0.35) PDK2HDAC4
SCHEMBL11349725 0.70 ADRB2 (0.41) TSHR
SCHEMBL11548754 0.70 HDAC4 (0.35) PDK2HDAC4
SCHEMBL11297051 0.70 POLB (0.39) OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0000825-B1 GEMINALLY DISUBSTITUTED INDENE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Kabi AB (SE) 1982-04-14 EP disclosed
US-4218472-A USED AS DECONGESANT, HYPOTENSIVE AGENT, VASOCONSTRICTOR, ANTI-RESERPINE AGENT, TREATING INCONTINENCE AB KABI (SE) 1980-08-19 US disclosed
EP-0000825-A1 Geminally disubstituted indene derivatives, processes for their preparation and pharmaceutical compositions containing them Kabi AB (SE) 1979-02-21 EP disclosed